<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS: To explore the relationship between various molecular makers and <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>METHOD: Using immunohistochemistry, protein expression of CEA, nm23, c-met, MMP2, COX- 2, VEGF, EGFR, and CD44 was assessed in 80 CRC cases </plain></SENT>
<SENT sid="2" pm="."><plain>The Chi-square test and logistic regression were performed to analyze the relationship between these indicators and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: There were significant differences in expression of CEA, MMP2, CD44, VEGF and EGFR between the <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> and non <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> groups (P &lt; 0.05); no significant differences were noted for nm23, c-met, and COX-2 expression </plain></SENT>
<SENT sid="4" pm="."><plain>Logistic regression analysis showed that only CEA, VEGF, and EGFR entered into the regression equation, and had significant correlations with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> (α inclusion= 0.10, α elimination = 0.15, R2 = 0.718) </plain></SENT>
<SENT sid="5" pm="."><plain>CONCLUSIONS: Combination detection of CEA, VEGF, and EGFR may be an effective means to predict <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Nm23, c-met, MMP2, COX-2, and CD44, in contrast, are not suitable as prognostic markers </plain></SENT>
</text></document>